Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Restoration of Central Vision With the PRIMA System in Patients With Atrophic Age-Related Macular Degeneration
Authors not listed
Science Corporation · 2020
Abstract
The objective of this study is to evaluate the efficacy and safety of the PRIMA System in patients with atrophic AMD. Eligible subjects will be implanted with the PRIMA Implant. The subjects will be assessed with various visual function and functional vision tests at defined timepoints throughout the clinical investigation with the PRIMA System (Implant and Visual Processor).
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-02 MST
Cite this
APA
Anonymous. (2020). Restoration of Central Vision With the PRIMA System in Patients With Atrophic Age-Related Macular Degeneration. <em>Science Corporation</em>. https://clinicaltrials.gov/study/NCT04676854
Vancouver
Anonymous. Restoration of Central Vision With the PRIMA System in Patients With Atrophic Age-Related Macular Degeneration. Science Corporation. 2020.
BibTeX
@misc{anon2020Restor,
title = {Restoration of Central Vision With the PRIMA System in Patients With Atrophic Age-Related Macular Degeneration},
author = {Anonymous},
journal = {Science Corporation},
year = {2020},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Rishi Singh 2012
Open access · US-GOV
A Single Arm, Investigator Initiated Study of the Efficacy, Safety, and Tolerability of Intravitreal Aflibercept Injection in Subjects With Exudative Age-related Macular Degeneration Previously Treated With Ranibizumab or Bevacizumab (ASSESS Study)
Allergan 2014
Open access · US-GOV
Retrospective Data Collection Study in Patients With Macular Oedema Receiving OZURDEX®
Seoul National University Hospital 2015
Open access · US-GOV
Safety and Efficacy Evaluation of Ultherapy™ System in Aging Hand
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 2024
Open access · US-GOV
Age-related Macular Degeneration of Atrophic Type Treated With Intravitreal Injection of Umbilical Cord Blood Enriched With Platelet Plasma: Multicenter Study.
Oklahoma State University Center for Health Sciences 2007
Open access · US-GOV
A Prospective Pilot Study of Reduced Fluence Photodynamic Therapy With Visudyne® (Verteporfin) in Combination With Lucentis™ (Ranibizumab) for the Treatment of Age-Related Macular Degeneration
GFPC Investigation 2024
Open access · US-GOV